Ascendis Pharma A/S (NASDAQ:ASND) Q1 2023 Earnings Call Tran

Operator: Thank you for standing by and welcome to the Q1 2023 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.

Related Keywords

Germany , United States , New York , America , Stina Singel , Tim Lee , Caroline Palomeque , Paul Choi , Transcon Pths , Tazeen Ahmad , Jessica Fye , Joseph Schwartz , Andreas Argyrides , Jan Mikkelsen , Derek Archila , David Lebovitz , Scott Smith , Vikram Purohit , Yaron Werber , Li Watsek , Joe Kelly , Leland Gershell , Ascendis Pharma , European Medicines Agency , Head Of Clinical Development Oncology , Access Program , European Union , European Commission , Goldman Sachs , Morgan Stanley , Jp Morgan , Wells Fargo , Call Transcript April , Pharma Earnings Conference , Senior Director , Investor Relations , Chief Executive Officer , Executive Vice President , Chief Financial Officer , Clinical Development Oncology , Senior Vice President , Private Securities Litigation Reform , Con Human Growth Hormone , Chief Executive , Extended Access Program , Sunday April , New Year , Again Andreas Argyrides , European Regulatory ,